company background image
ZOTA

Zota Health CareNSEI:ZOTA Stock Report

Market Cap

₹10.0b

7D

8.3%

1Y

180.3%

Updated

02 Dec, 2021

Data

Company Financials
ZOTA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends1/6

ZOTA Stock Overview

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India.

Zota Health Care Competitors

Jenburkt Pharmaceuticals

BSE:524731

₹2.5b

Sakar Healthcare

NSEI:SAKAR

₹2.3b

Cian Healthcare

BSE:542678

₹390.1m

Deccan Health Care

BSE:542248

₹447.8m

Price History & Performance

Summary of all time highs, changes and price drops for Zota Health Care
Historical stock prices
Current Share Price₹396.65
52 Week High₹438.95
52 Week Low₹136.65
Beta0.60
1 Month Change7.02%
3 Month Change4.88%
1 Year Change180.32%
3 Year Change117.22%
5 Year Changen/a
Change since IPO277.63%

Recent News & Updates

Sep 20
Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00

Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00

Zota Health Care Limited's ( NSE:ZOTA ) investors are due to receive a payment of ₹1.00 per share on 30th of October...

Sep 04
Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00

Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00

The board of Zota Health Care Limited ( NSE:ZOTA ) has announced that it will pay a dividend of ₹1.00 per share on the...

Shareholder Returns

ZOTAIN PharmaceuticalsIN Market
7D8.3%-0.1%-1.7%
1Y180.3%12.1%41.1%

Return vs Industry: ZOTA exceeded the Indian Pharmaceuticals industry which returned 12.1% over the past year.

Return vs Market: ZOTA exceeded the Indian Market which returned 41.1% over the past year.

Price Volatility

Is ZOTA's price volatile compared to industry and market?
ZOTA volatility
ZOTA Average Weekly Movement6.6%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market3.9%

Stable Share Price: ZOTA is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: ZOTA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995321Moxesh Zotahttps://www.zotahealthcare.com

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others.

Zota Health Care Fundamentals Summary

How do Zota Health Care's earnings and revenue compare to its market cap?
ZOTA fundamental statistics
Market Cap₹9.98b
Earnings (TTM)₹48.41m
Revenue (TTM)₹1.30b

206.1x

P/E Ratio

7.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ZOTA income statement (TTM)
Revenue₹1.30b
Cost of Revenue₹883.15m
Gross Profit₹419.88m
Expenses₹371.47m
Earnings₹48.41m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.92
Gross Margin32.22%
Net Profit Margin3.72%
Debt/Equity Ratio0.0%

How did ZOTA perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

51%

Payout Ratio

Valuation

Is Zota Health Care undervalued compared to its fair value and its price relative to the market?

34.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ZOTA (₹396.65) is trading below our estimate of fair value (₹601.41)

Significantly Below Fair Value: ZOTA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ZOTA is poor value based on its PE Ratio (206.1x) compared to the Indian Pharmaceuticals industry average (22.5x).

PE vs Market: ZOTA is poor value based on its PE Ratio (206.1x) compared to the Indian market (18.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ZOTA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ZOTA is overvalued based on its PB Ratio (11.1x) compared to the IN Pharmaceuticals industry average (2.8x).


Future Growth

How is Zota Health Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

20.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zota Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Zota Health Care performed over the past 5 years?

-30.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ZOTA has high quality earnings.

Growing Profit Margin: ZOTA's current net profit margins (3.7%) are higher than last year (2.8%).


Past Earnings Growth Analysis

Earnings Trend: ZOTA's earnings have declined by 30.2% per year over the past 5 years.

Accelerating Growth: ZOTA's earnings growth over the past year (85%) exceeds its 5-year average (-30.2% per year).

Earnings vs Industry: ZOTA earnings growth over the past year (85%) exceeded the Pharmaceuticals industry 29.2%.


Return on Equity

High ROE: ZOTA's Return on Equity (5.4%) is considered low.


Financial Health

How is Zota Health Care's financial position?


Financial Position Analysis

Short Term Liabilities: ZOTA's short term assets (₹831.8M) exceed its short term liabilities (₹304.0M).

Long Term Liabilities: ZOTA's short term assets (₹831.8M) exceed its long term liabilities (₹10.7M).


Debt to Equity History and Analysis

Debt Level: ZOTA is debt free.

Reducing Debt: ZOTA has no debt compared to 5 years ago when its debt to equity ratio was 13.1%.

Debt Coverage: ZOTA has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ZOTA has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Zota Health Care current dividend yield, its reliability and sustainability?

0.25%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ZOTA's dividend (0.25%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.36%).

High Dividend: ZOTA's dividend (0.25%) is low compared to the top 25% of dividend payers in the Indian market (1.5%).


Stability and Growth of Payments

Stable Dividend: ZOTA has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: ZOTA has only been paying a dividend for 4 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (50.7%), ZOTA's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.3yrs

Average management tenure


CEO

Moxesh Zota (31 yo)

5.17yrs

Tenure

₹2,577,000

Compensation

Mr. Moxesh Ketanbhai Zota has been Managing Director and Director at Zota Health Care Limited since October 7, 2016. Mr. Zota is young entrepreneur with experience of 2 years in the industry and forays exp...


CEO Compensation Analysis

Compensation vs Market: Moxesh's total compensation ($USD34.43K) is about average for companies of similar size in the Indian market ($USD39.93K).

Compensation vs Earnings: Moxesh's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ZOTA's management team is seasoned and experienced (7.3 years average tenure).


Board Members

Experienced Board: ZOTA's board of directors are considered experienced (5.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ZOTA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.


Top Shareholders

Company Information

Zota Health Care Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Zota Health Care Limited
  • Ticker: ZOTA
  • Exchange: NSEI
  • Founded: 1995
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹9.980b
  • Shares outstanding: 25.16m
  • Website: https://www.zotahealthcare.com

Number of Employees


Location

  • Zota Health Care Limited
  • Zota House
  • 2/896, Hira Modi Street
  • Surat
  • Gujarat
  • 395002
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/02 16:14
End of Day Share Price2021/12/02 00:00
Earnings2021/09/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.